From: Physician and patient preferences for dosing options in migraine prevention
Physicians (N = 400) | |
---|---|
Age, years, mean (range) | 49 (23–74) |
Women, % | 75 |
Ethnicity, % | |
White/Caucasian | 67 |
Asian/Pacific Islander | 24 |
Hispanic/Latino | 3 |
Black/African American | 3 |
Years in practice, year | 16.5 |
Patient volume, number of patients per month | |
Adult patients | 379 |
Adult patient with migraine | 84 |
Patient type, % | |
CM (≥15 headache days/month) | 20 |
High-frequency EM (10–14 headache days/month) | 23 |
Moderate-frequency EM (5–9 headache days/month) | 30 |
Patient insurance, % | |
Private/commercial | 53 |
Medicare Part D | 24 |
Medicaid | 8 |
ACA | 8 |
VA/TRICARE | 4 |
Practice setting, % | |
Office-based | 87 |
Hospital-based | 13 |